Dr. Moore on the NOVA Trial for Ovarian Cancer

Dr. Moore on the NOVA Trial for Ovarian Cancer

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel ApproachesПодробнее

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel Approaches

Dr. Moore on Unanswered Questions With PARP Inhibitors in Ovarian CancerПодробнее

Dr. Moore on Unanswered Questions With PARP Inhibitors in Ovarian Cancer

Ongoing PARP Trials in Recurrent Ovarian CancerПодробнее

Ongoing PARP Trials in Recurrent Ovarian Cancer

Rucaparib for Recurrent Ovarian CancerПодробнее

Rucaparib for Recurrent Ovarian Cancer

Niraparib Maintenance for Recurrent Ovarian CancerПодробнее

Niraparib Maintenance for Recurrent Ovarian Cancer

Dr. Moore on the Results of the NOVA Trial in Ovarian CancerПодробнее

Dr. Moore on the Results of the NOVA Trial in Ovarian Cancer

Ongoing PARP Inhibitor Research in Ovarian CancerПодробнее

Ongoing PARP Inhibitor Research in Ovarian Cancer

Design of the NOVA Trial for Ovarian CancerПодробнее

Design of the NOVA Trial for Ovarian Cancer